Given that the majority of men with these features had them synchronously with other features, thereby simplifying GPs’ investigation decisions, future research to improve prostate-cancer outcomes in Black men could focus more on ways to maximise the usage of PSA testing in primary care. The gene discussed is KLK3; the disease is prostate carcinoma.